TCAP function has not been fully characterized.

Autosomal recessive limb-girdle muscular dystrophy type 2G is associated with mutations in the TCAP gene on chromosome 17.

Genetic testing for TCAP is available. Testing is considered confirmatory for diagnosis.

Biomarker and diagnostic research for autosomal recessive limb-girdle muscular dystrophy type 2G has been reported in the published literature.

Estimated prevalence: <1 in 1,000,000 (VERY_RARE).

No clinical trials have been registered for autosomal recessive limb-girdle muscular dystrophy type 2G.

2 publications have been identified in PubMed for autosomal recessive limb-girdle muscular dystrophy type 2G. Research spans Diagnostic / Biomarker (50%) and Review / Meta-Analysis (50%).

Recent Publications

• Paprad T (2025). [PMID: 40195250](https://pubmed.ncbi.nlm.nih.gov/40195250/). *Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology*. [Diagnostic / Biomarker]

• Politano L (2024). [PMID: 38791328](https://pubmed.ncbi.nlm.nih.gov/38791328/). *International journal of molecular sciences*. [Review / Meta-Analysis]